Prolongation of concordant islet xenografts with leflunomide.
Lakey
J R
JR
Surgical-Medical Research Institute, University of Alberta, Edmonton, Canada.
Yatscoff
R W
RW
Koshal
A
A
Rajotte
R V
RV
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D015925:Cryopreservation; D003921:Diabetes Mellitus, Experimental / Q000601:surgery*; D006085:Graft Survival / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007515:Islets of Langerhans; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D051379:Mice; D008807:Mice, Inbred BALB C; D051381:Rats; D011920:Rats, Inbred WF; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology*
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide